Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Ino Nitric Oxide: Mod to Ex Opt Yr 2, Clin 2001 is a federal award for Naval Medical Center San Diego Ca held by Ino Therapeutics LLC. Estimated value $603K ($310K obligated). Current period of performance ends Jan 9, 2024. Last award drew 1 bidder. Place of performance: HAMPTON NJ.
Ino nitric oxide: mod to ex opt yr 2, clin 2001. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Jan 9, 2024 (1016 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on N0025921F0021? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordIno Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract N0025921F0021?
N0025921F0021 (Ino nitric oxide: mod to ex) is a Naval Medical Center San Diego Ca award with a potential value of $603K, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is N00259-21-F-0021?
N00259-21-F-0021 is the dashed form of PIID N0025921F0021 (Ino nitric oxide: mod to ex), held by Ino Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded N0025921F0021?
Naval Medical Center San Diego Ca awarded N0025921F0021 to Ino Therapeutics LLC (potential $603K).
Who is the incumbent on N0025921F0021?
Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Jan 9, 2024.
When does Ino Therapeutics LLC’s N0025921F0021 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 9, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on N0025921F0021? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.